PI3KCA Could Predict Aspirin Response in Colorectal Cancer

In the VICTOR trial, patients with PI3KCA-positive colorectal cancer who took aspirin had a lower cancer recurrence compared to those with a wild-type PI3KCA gene.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news